Oxytocin.

Nonapeptide hormone — bonding, intimacy and prosocial neuromodulation.

Select strengthPer-vial price

Quantity

Total

€25.00· 1 vial

Build your bag, then either book a consultation (an EU-licensed physician reviews your file — anything declined is refunded) or upload an existing Rx at checkout.

✓Magistral preparation — Directive 2001/83/EC Art. 5(1).
✓Patient-named prescription only — dispensed against a valid Rx.
✓EU-GMP Annex 1 Grade A/B cleanroom compounding.
✓Cold-chain shipping across EU/EEA — 2–5 working days.

Overview

About Oxytocin.

Oxytocin is a 9-amino-acid neurohypophyseal hormone with both peripheral (uterine contraction, lactation) and central (social bonding, stress buffering) effects. Licensed pharmaceutical preparations are widely available for obstetric use.

Off-label magistral use targets the prosocial and intimacy-supporting effects, generally at low doses given intranasally or by injection.

Mechanism of action

Oxytocin binds the oxytocin receptor (OXTR) on many cell types. Centrally, it modulates amygdala reactivity (dampening threat response) and ventral-tegmental dopamine release (enhancing reward of social interaction). Peripherally, it acts on uterine smooth muscle and mammary myoepithelium.

Posology · for information only

Subcutaneous injection, typically 5–10 IU per dose. Intranasal administration is more common for prosocial protocols.

Your physician sets the prescription. This is descriptive information, not a self-administration guide.

Storage

Lyophilised: store at 2–8 °C, protect from light. Once reconstituted: 2–8 °C, use within 30 days. Do not freeze.

Evidence baseClinical RCT evidence

Indications studied

Pair bondingStress bufferingIntimacy support

Identification & specifications

INN / Name: Oxytocin
Form: Lyophilised vial · subcutaneous injection
Strength: 5mg vial
Manufacturing: EU-GMP Annex 1 · Grade A/B
Endotoxins: European Pharmacopoeia 2.6.14 · LAL assay
Identity & purity: HPLC + MS · > 98%
Cold chain: Validated 2–8 °C, monitored end-to-end
Regulatory basis: Directive 2001/83/EC · Article 5(1)

Logistics

2–5 working days

EU / EEA cold-chain delivery, 2–8 °C monitored end-to-end with digital temperature log. Tracking link sent on dispatch.

Legal status

Magistral preparation

Patient-named preparation under Directive 2001/83/EC Article 5(1). Dispensed exclusively against a valid EU prescription.

Cross-border

EU prescription recognition

Prescriptions written in one EU member state are recognised in others under Directive 2011/24/EU on cross-border healthcare.

Same therapeutic axis

Within Reproductive & Hormonal Health.

All Reproductive & Hormonal Health preparations